Oxford Immunotec Global PLC announced that Louis O'Dea, MB, BCh, BAO, has joined the company as Chief Medical Officer. Dr. O'Dea will support the continued growth of its current T-SPOT.TB business and the development of new products through management of its medical education and clinical trial programs. Prior to joining Oxford Immunotec, Dr. O'Dea served as the Chief Medical Officer and Head of Regulatory Affairs at Moderna Therapeutics.